TABLE 4.
Cryopreservations methods used by each site.
| Site #1 | Site #2 | Site #3 | Site #4 | Site #55 | |
| Cell concentration | 1–10 × 106 Cells/mL | 1–10 × 106 Cells/mL | 1.5–5 × 106 Cells/mL | 5 × 106 Cells/mL | 1–5 × 106 Cells/mL |
| Final Freezing Solution | 30% Plasmalyte-A, 10% DMSO, 2.5% Human serum albumin | Plasmalyte A, 6% Pentastarch, 5% DMSO, 2%, Human serum albumin | 60% D-MEM, 30% Hyclone FBS, 10% DMSO | MEM-Eagle 15% FBS, 10% DMSO | 90% FBS, 10% DMSO |
| Freezing Method | Control Rate Freezer | Mr. Frosty Freezing Container | Mr. Frosty Freezing Container | No Container | Mr. Frosty Freezing Container |
| Start Chamber = 0.0°C; | −80°C O/N; transfer | −80°C O/N; transfer | −80°C O/N; maintain | −80°C O/N; transfer | |
| Sample = 1.0°C | to LN2 freezer | to LN2 freezer | in −80°C freezer | to LN2 freezer | |
| Ramp 1.0°C/min until | |||||
| Sample = –12.0°C | |||||
| Ramp 20.0°C/min until | |||||
| Chamber = –60.0°C | |||||
| Ramp 15.0°C/min until | |||||
| Chamber = –18.0°C | |||||
| Ramp 1.0°C/min until | |||||
| Sample = –60.0°C | |||||
| Ramp 3.0°C/min until | |||||
| Sample = –100.0°C | |||||
| End and transfer to LN2 | |||||
| Freezer | |||||
| Storage freezer | LN2 | LN2 | LN2 | −80°C | LN2 |